The wild-type ZH501 strain of Rift Valley fever (RVF) virus and two small-plaque strains (T1 and T46) derived from it were characterized by plaque size, pathogenicity for hamsters and ability to replicate in Vero cells. Additionally, a mutagenized, attenuated, large-plaque, vaccine-candidate strain of RVF virus (ZH548-M12) was also studied. Infections with either the ZH501 or T46 strain were uniformly fatal to hamsters. In contrast, nearly all hamsters infected with either the T1 or ZH548-M12 strains survived and were immune to challenge with 105 LD50 of the ZH501 strain. Both of these attenuated strains failed to replicate in Vero cells maintained at 41 °C, whereas the more virulent strains (ZH501 and T46) replicated at this temperature. The low virulence and ability to induce protection against lethal RVF virus challenge that is associated with the T1 and ZH548-M12 strains make them potential vaccine candidates.
CAPLENH., PETERSC. J., BISHOPD. H. L.1985; Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. Journal of General Virology 66:2271–2277
COETZERJ. A. W., BARNARDB. J. H.1977; Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with Wesselbron disease and Rift Valley fever viruses as aetiological agents. Onderstepoort Journal of Veterinary Research 44:119–126
EARLEYE., PERALTAP. H., JOHNSONK. M.1967; A plaque neutralization method for arboviruses. Proceedings of the Society for Experimental Biology and Medicine 125:741–747
GARGANT. P.II, BAILEYC. L., HIGBEEG. A., GADA., EL SAIDS.1983; The effect of laboratory colonization on the vector-pathogen interactions of Egyptian Culex pipiens and Rift Valley fever virus. American Journal of Tropical Medicine and Hygiene 32:1154–1163
MEEGANJ. M.1979; The Rift Valley fever epizootic in Egypt 1977-1978. 1. Description of the epizootic and virological studies. Transactions of the Royal Society of Tropical Medicine and Hygiene 73:618–623
MORRILLJ. C, JENNINGSG. B., CAPLENH., TURELLM. J., JOHNSONA. J., PETERSC. J.1987; Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. American Journal of Veterinary Research 48:1042–1047
MOUSSAM. I., WOODO. L., ABDEL WAHABK. S. E.1982; Reduced pathogenicity associated with a small plaque variant of the Egyptian strain of Rift Valley fever virus (ZH501). Transactions of the Royal Society of Tropical Medicine and Hygiene 76:482–486
PETERSC. J., ANDERSONG. W.JR1981 Pathogenesis of Rift Valley fever. Contributions to Epidemiology and Biostatistics321–41 Edited by SwartzT. A., KlingbergM. A., GoldblumN., PapierC. M. Basel: S. Karger;
SMITHBURNK. C.1949; Rift Valley fever: the neurotropic adaption of virus and experimental use of this modified virus as a vaccine. British Journal of Experimentai Pathology 30:1–16
VAN HOOSIERG. L.JR, LADIGESW. C.1984 Biology and diseases of hamsters. Laboratory Animal Medicine123–147 Edited by FoxJ., CohenB., LoewF. New York & London: Academic Press;